Predictors of Short-Term Visual Outcome after Anti-VEGF Therapy of Macular Edema due to Central Retinal Vein Occlusion
Investigative Ophthalmology & Visual Science2010Vol. 52(6), pp. 3334–3334
Citations Over TimeTop 10% of 2010 papers
Sebastián Wolf, Ramzi Ghanem, Simon P. Rothenbuehler, Volker Enzmann, Carsten Framme, Sebastián Wolf
Abstract
Depending on the integrity of the outer retinal layers, the authors observed rapid and clinically relevant improvement in BCVA after the first anti-VEGF injection. In the development of an optimal treatment regime, the indication for treatment and re-treatment should be based on functional and morphologic findings, such as the deterioration of outer retinal layers. Intact ELM in SD-OCT imaging is associated with better visual outcomes after intravitreal anti-VEGF treatment in patients with ME secondary to CRVO.
Related Papers
- → Role of Cytokines in Ranibizumab Therapy for Macular Edema in Patients with Central Retinal Vein Occlusion(2019)16 cited
- → Ranibizumab: in macular oedema following retinal vein occlusion.(2011)12 cited
- → Clinical Application Analysis of Calcium Dobesilate Combined with Ranibizumab in Patients with Macular Edema Secondary to Branch Retinal Vein Occlusion(2022)
- → CO35 Real-World Effectiveness of Intravitreal Ranibizumab and Aflibercept for Eyes with Central Retinal Vein Occlusion: A Multi-Institutional Cohort Study in Taiwan(2023)